GlassScriptPhysician profile
Victor Okunrintemi
NPI 1578054854
$11,807.29
in general payments reported to CMS, 2019-2025
22 companies · $785 in 2025
The $785 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.86 · 2022: $1,009 · 2023: $3,439 · 2024: $6,523 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,640 · Travel and Lodging: $2,646 · Grant: $2,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,640.05 |
| Travel and Lodging | $2,646.12 |
| Grant | $2,461.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,018.74 | 2023-2025 | Watchman Flx, Avvigo Guidance System, Synergy |
| Abbott Laboratories | $2,761.63 | 2024-2025 | Optis, Diamondback Peripheral, Supera |
| Medtronic, INC. | $1,392.87 | 2021-2025 | Corevalve Evolut R, Telescope, Hawkone |
| Terumo Medical Corporation | $1,282.10 | 2024 | Glidesheath Slender, Metacross Otw, Optitorque |
| Amgen INC. | $588.47 | 2022-2024 | Repatha |
| Abiomed | $242.83 | 2024-2025 | Impella |
| Pfizer INC. | $237.68 | 2023-2025 | |
| Biotronik INC. | $232.90 | 2022-2024 | Orsiro Mission |
| Edwards Lifesciences Corporation | $196.24 | 2022-2023 | The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $178.27 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.88 | 2022-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $117.82 | 2025 | Lifevest |
| Biosense Webster, INC. | $103.65 | 2024 | Carto 3 |
| Lantheus Medical Imaging, INC. | $96.30 | 2023-2024 | Definity |
| Regeneron Healthcare Solutions, INC. | $41.48 | 2025 | Evkeeza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $38.48 | 2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $38.35 | 2025 | |
| Alnylam Pharmaceuticals INC. | $29.93 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.09 | 2024 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $18.29 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.32 | 2025 | Wainua |
| Recor Medical INC | $15.97 | 2025 | Paradise Ultrasound Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Okunrintemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.